Regular ArticleRecycling of the 67-kDa Elastin Binding Protein in Arterial Myocytes Is Imperative for Secretion of Tropoelastin
Abstract
We have shown previously that the 67-kDa elastin binding protein (EBP) colocalizes intracellularly and extracellularly with tropoelastin in fetal sheep aorta, suggesting that these two proteins associate along the secretory pathway. Moreover, we have established that association with EBP protects tropoelastin from serine proteinases and from intracellular coacervation, and is necessary for its proper extracellular assembly. Since the production of tropoelastin by aortic smooth muscle cells (Ao SMC) exceeds production of the EBP, we speculated that this binding protein might recycle back into the cell, associating again with newly synthesized tropoelastin. In this report we labeled cultured Ao SMC externally with the F(ab′)2 fragments of immunoglobulin which recognizes sheep EBP and followed trafficking of EBP by immunofluorescence and electron microscopy. Our results indicate that the majority of the EBP residing on the cell surface can be internalized to endocytic compartments (but not to lysosomes) and recycled back to the plasma membrane within 45-60 min. We have also determined that reagents disturbing pH of distinct endocytic compartments (chloroquine and bafilomycin A1, but not ammonium chloride) arrest recycling of the EBP and, at the same time, strongly inhibit deposition of insoluble elastin in cultures of sheep Ao SMC and in organ cultures of chicken aorta. In contrast, neither chloroquine nor bafilomycin A1 inhibit total protein synthesis or synthesis of tropoelastin. Our results suggest that the EBP serves as a reusable shuttle protein for tropoelastin and that its recycling is essential for effective deposition of insoluble elastin.
References (0)
Cited by (55)
Structural proteins | The biochemistry of elastin
2021, Encyclopedia of Biological Chemistry: Third EditionElastin is the polymeric protein responsible for the unusual properties of extension and elastic recoil essential for the physiological function of elastic tissues. We describe the current state of knowledge of the synthesis and structure of tropoelastin, and the role of protein sequence in promoting the balance of structural order/disorder required for polymeric assembly and functional properties as an entropic elastomer. We also discuss how mutations in tropoelastin and other matrix-associated proteins can affect structural durability of the polymer, and the use of elastin as a biomimetic model for design of protein-based structural materials.
Elastin architecture
2019, Matrix BiologyElastic fibers are an essential component of the extracellular matrix where they provide structural integrity and elastic recoil in a number of important tissues. A major constituent of these fibers is elastin, an insoluble metabolically stable polymer formed via extensive crosslinking of the monomeric precursor tropoelastin. Research over the past few decades has shown that tropoelastin possesses unique structural features that differ from both intrinsically disordered and globular proteins. This review details the advances in our understanding of tropoelastin's structural properties and illustrates how these dictate its biological function.
Elastic fibers and elastin receptor complex: Neuraminidase-1 takes the center stage
2019, Matrix BiologyExtracellular matrix (ECM) has for a long time being considered as a simple architectural support for cells. It is now clear that ECM presents a fundamental influence on cells driving their phenotype and fate. This complex network is highly specialized and the different classes of macromolecules that comprise the ECM determine its biological functions. For instance, collagens are responsible for the tensile strength of tissues, proteoglycans and glycosaminoglycans are essential for hydration and resistance to compression, and glycoproteins such as laminins facilitate cell attachment. The largest structures of the ECM are the elastic fibers found in abundance in tissues suffering high mechanical constraints such as skin, lungs or arteries. These structures present a very complex composition whose core is composed of elastin surrounded by a microfibrils mantle. Elastogenesis is a tightly regulated process involving the sialidase activity of the Neuraminidase-1 (Neu-1) sub-unit of the Elastin Receptor Complex. Interestingly, Neu-1 subunit also serves as a sensor of elastin degradation via its ability to transmit elastin-derived peptides signaling. Finally, reports showing that neuraminidase activity is able to regulate TGF-β activation raises questions about a possible role for Neu-1 in elastic fibers remodeling.
In this mini review, we develop the concept of the regulation of the whole life of elastic fibers through an original scope, the key role of Neu-1 sialidase enzymatic activity.
Vascular wall extracellular matrix proteins and vascular diseases
2014, Biochimica et Biophysica Acta - Molecular Basis of DiseaseExtracellular matrix proteins form the basic structure of blood vessels. Along with providing basic structural support to blood vessels, matrix proteins interact with different sets of vascular cells via cell surface integrin or non-integrin receptors. Such interactions induce vascular cell de novo synthesis of new matrix proteins during blood vessel development or remodeling. Under pathological conditions, vascular matrix proteins undergo proteolytic processing, yielding bioactive fragments to influence vascular wall matrix remodeling. Vascular cells also produce alternatively spliced variants that induce vascular cell production of different matrix proteins to interrupt matrix homeostasis, leading to increased blood vessel stiffness; vascular cell migration, proliferation, or death; or vascular wall leakage and rupture. Destruction of vascular matrix proteins leads to vascular cell or blood-borne leukocyte accumulation, proliferation, and neointima formation within the vascular wall; blood vessels prone to uncontrolled enlargement during blood flow diastole; tortuous vein development; and neovascularization from existing pathological tissue microvessels. Here we summarize discoveries related to blood vessel matrix proteins within the past decade from basic and clinical studies in humans and animals — from expression to cross-linking, assembly, and degradation under physiological and vascular pathological conditions, including atherosclerosis, aortic aneurysms, varicose veins, and hypertension.
Proteins and Poly(Amino Acids)
2014, Natural and Synthetic Biomedical PolymersOver the last two decades, significant advances have been made in the development of natural and synthetic biomaterials for biomedical applications. The overarching goal for most of these biomaterials is its ability to closely mimic native extracellular matrix of tissues. Most common sources of natural biomaterials have been of allogeneic origin, primarily due to its biocompatibility and ability to remodel in situ and eventually degrade to allow for tissue repair and regeneration. The most common of them being collagen, fibrin, elastin, and more recently silk. However, the cost associated with acellular allogeneic or xenogeneic tissues and its minimal availability has lead to development and characterization of other classes of protein-derived biomaterials. One such class, poly(amino acids) (PAA), composed of polymeric chains of single or multiple amino acids, has been receiving tremendous interest over the last decade. Such PAA-derived materials have been applied in several areas of biomedical engineering including coatings for therapeutic devices, scaffolds for tissue engineering, and as micro- and nanoparticles for controlled release. This review summarizes the synthesis, fabrication, characterization, and critical applications of some of these common poly(amino acids), such as poly(glutamic acid), poly-l-lysine, poly(aspartic acid), and cyanophycin, and the recent advances made in this area over the last 20 years.
Interaction between the elastin peptide VGVAPG and human elastin binding protein
2013, Journal of Biological ChemistryThe elastin binding protein (EBP), a spliced variant of lysosomal β-galactosidase, is the primary receptor of elastin peptides that have been linked to emphysema, aneurysm and cancer progression. The sequences recognized by EBP share the XGXXPG consensus pattern found in numerous matrix proteins, notably in elastin where the VGVAPG motif is repeated. To delineate the elastin binding site of human EBP, we built a homology model of this protein and docked VGVAPG on its surface. Analysis of this model suggested that Gln-97 and Asp-98 were required for interaction with VGVAPG because they contribute to the definition of a pocket thought to represent the elastin binding site of EBP. Additionally, we proposed that Leu-103, Arg-107, and Glu-137 were essential residues because they could interact with VGVAPG itself. Site-directed mutagenesis experiments at these key positions validated our model. This work therefore provides the first structural data concerning the interaction of the VGVAPG with its cognate receptor. The present structural data should now allow the development of EBP-specific antagonists.
Background: The interaction of the peptide VGVAPG with the elastin binding protein is critically involved in aneurysm progression.
Results: A molecular model of this interaction is proposed and explored using a site-directed mutagenesis strategy.
Conclusion: Three residues, Leu-103, Arg-107, and Glu-137, of elastin binding protein are critical players in this interaction.
Significance: Our data now allow the design of antagonists of VGVAPG.